Sign in
Already have access? Choose your edition
Sign-in is edition-specific. New here? Start with the free brief instead of jumping straight into a trial.
Each edition has its own app, pricing, and coverage page. Use sign-in if you already have access; otherwise pick an edition and get the free daily + weekly brief first.
AI
Daily briefings on AI labs, policy, tooling, and community shifts.
Best for
- Model releases + evals
- Policy and safety narratives
- Tooling and platform shifts
Featured signalUnlocked today
In Q1 2026, Google Search queries reached an all-time high, driven by AI enhancements and strong user engagement. CEO Sundar Pichai highlighted AI's role in...
Crypto
Daily briefings on markets, protocols, narratives, and risk events.
Best for
- Market structure + regulation
- Security and exploit narratives
- Protocol + dev ecosystem
Featured signalUnlocked today
Meta has started offering stablecoin payouts in USDC to select creators in Colombia and the Philippines via Stripe, marking its first crypto payout program s...
CYBERSECURITY
Daily briefings on vulnerabilities, incidents, and threat intel.
Best for
- Vulns and advisories
- Incidents + exploit narratives
- Vendor and community disclosures
Featured signalUnlocked today
A critical local privilege escalation vulnerability, CVE-2026-31431, nicknamed 'Copy Fail,' has been disclosed affecting Linux kernels released since 2017.
ENERGY
Daily briefings on the energy transition: policy, grid, storage, and markets.
Best for
- Grid + reliability narratives
- Policy + first-party data
- Storage + transition supply chain
Featured signalUnlocked today
At a landmark climate conference in Santa Marta, Colombia, nearly 60 countries agreed to develop voluntary national roadmaps to phase out coal, oil, and gas...
BIOTECH
Daily briefings on clinical, regulatory, and R&D updates from public sources.
Best for
- Clinical + regulatory narratives
- Research + preprints
- Funding + market updates
Featured signalUnlocked today
Avalyn Pharma has completed an oversized initial public offering, raising $300 million to fund the late-stage development of its inhaled reformulations of ap...